澳大利亚的药用大麻使用量在2026年猛增,有240万使用者和13亿美元的支出,因为尽管有广告禁令,药房仍在扩大。 Australia's medicinal cannabis use surged in 2026, with 2.4 million users and $1.3 billion in spending, as dispensaries expanded despite advertising bans.

2026年,澳大利亚的药用大麻部门正在迅速扩大,新的商店药房在悉尼和墨尔本等城市提供谨慎、注重健康的空间。 In 2026, Australia’s medicinal cannabis sector is expanding rapidly, with new boutique dispensaries offering discreet, wellness-focused spaces in cities like Sydney and Melbourne. 过去一年,有240多万澳大利亚人在接受和需求增加的驱动下使用药用大麻,预计到2023年开支将达到13亿美元。 Over 2.4 million Australians used medicinal cannabis in the past year, driven by growing acceptance and demand, with spending projected to reach $1.3 billion by 2023. 尽管治疗物品管理局禁止宣传处方药,但药房以“整体健康”等术语运作,以避免检查。 Despite regulatory restrictions from the Therapeutic Goods Administration that ban advertising of prescription medicines, dispensaries operate under terms like “holistic health” to avoid scrutiny. 虽然大约80%的社区药房已经发放了该产品,但开具的处方仍然仅限于一小批专家。 While about 80% of community pharmacies have dispensed the product, prescribing remains limited to a small group of specialists. 这些诊所旨在通过培养支持性、面向社区的环境,使病人能够与工作人员和同龄人建立信任,从而减少耻辱和焦虑。 These clinics aim to reduce stigma and anxiety by fostering supportive, community-oriented environments where patients build trust with staff and peers.